Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HER-PCI trial of prophylactic cranial irradiation in HER2-positive metastatic breast cancer treated with trastuzumab
ISRCTN64624715Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Apr 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, open-label trial of trastuzumab in breast cancer (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Incidence of symptomatic brain metastases. Started Apr 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN64624715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64624715.